Loading clinical trials...
Loading clinical trials...
This two-stage study will compare consented research participants with tuberculous meningitis receiving BPaLMZ to controls receiving SOC of rifampicin (R), isoniazid (H), pyrazinamide (Z), and ethambu...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
University of Minnesota
Collaborators
NCT05590455 · Tuberculous Meningitis, HIV I Infection
NCT05383742 · Tuberculous Meningitis
NCT03100786 · Tuberculosis, Tuberculous Meningitis, and more
NCT05917340 · Tuberculous Meningitis
NCT01802502 · Tuberculous Meningitis
University of Minnesota
Minneapolis, Minnesota
Infectious Diseases Institute
Kampala
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions